Apotea reports strong growth and profitability
Net sales increased by 10.9% during the second quarter. EBIT margins stabilized at 5.2% despite higher depreciation.
See the latest news and media coverage for Apotea. We track all announcements, press releases, and industry mentions in real time, all in one place.
Online pharmacy and health retailer
apotea.seLast updated
In short: Apotea delivered strong 2026 growth despite a Q4 2025 profit warning and regulatory scrutiny.
Net sales increased by 10.9% during the second quarter. EBIT margins stabilized at 5.2% despite higher depreciation.
The meeting also approved new incentive programs and re-elected the board.
The report shows profitable growth, investments and the first CSRD report. Sustainability Director Erika Svensson emphasizes improved structure and follow-up.
Net sales increased 10.5% to 1937 MSEK. EBIT rose to 101 MSEK with 5.2% margin. Stable growth and improved gross margin.
Apotea increases revenue and profit in the second quarter. The pharmacy giant continues its work to further increase growth in the long term.
Earnings call Apotea delivered Q1 revenues of SEK 1.937 billion, up 10.5% YoY, with an operating margin of 5.2% and strong cash flow. Management maintained...
Net revenue for the first quarter increased by 10.5% (15.2) to SEK 1,937.2 million (1,753.5) and operating profit (EBIT) amounted to SEK 101.3 million (92.4...
Close LIVE: Stock Morning April 29. The expertise and treatments in women's health already exist - but the healthcare system has not kept up with either the medical or...
Track Apotea and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.